Dr. Andy Moye, Paige AI, on Exploring AI's Role in Transforming Cancer Diagnostics

The Pulse by Wharton Digital Health

In this episode, I sat down with Dr. Andy Moye, CEO of Paige AI. Founded in 2017, Paige is a digital pathology software provider that uses AI to improve cancer diagnoses. Paige is currently the only company with FDA approval for an AI based product, and they are also collaborating with Microsoft to build the world's largest image-based AI cancer model. In this episode, Dr. Moye and I discuss the journey of Paige's origin as a spin-out from Memorial Sloan Kettering, the role of AI in supporting cancer diagnostics, the process of navigating corporate partnerships and FDA approval with AI tools, and the value of new AI applications in healthcare.